Cellcept and Propulsid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Propulsid (cisapride monohydrate). Common drug interactions include headache among females and rhabdomyolysis among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Propulsid. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Propulsid?

Propulsid has active ingredients of cisapride monohydrate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 8,130 Propulsid users. Check the latest studies of Propulsid.



On Jul, 10, 2026

31 people who take Cellcept and Propulsid together, and have interactions are studied.

Cellcept and Propulsid drug interactions.

What are the common drug interactions of Cellcept and Propulsid, by gender? *:

female:

  1. Headache (pain in head)
  2. Hepatotoxicity (chemical-driven liver damage)
  3. Hyperglycaemia (high blood sugar)
  4. Inflammation
  5. Intestinal functional disorder
  6. Lethargy (tiredness)
  7. Meningitis viral (viral inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  8. Myalgia (muscle pain)
  9. Pallor
  10. Pancreatic insufficiency

male:

  1. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  2. Blood creatine phosphokinase increased
  3. Renal impairment (severely reduced kidney function)
  4. Weakness
  5. Aldolase increased
  6. Amputation
  7. B-cell lymphoma (blood cancer affecting b cells)
  8. Bradycardia (abnormally slow heart action)
  9. Cardiac arrest
  10. Chest pain

What are the common drug interactions of Cellcept and Propulsid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Drug level increased
  2. Dyspepsia (indigestion)
  3. Blood creatinine increased
  4. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  5. Renal failure (kidney dysfunction)

20-29:

  1. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  2. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  3. Pain

30-39:

  1. Blood creatinine increased
  2. Headache (pain in head)
  3. Upper respiratory tract infection

40-49:

  1. Colitis (inflammation of colon)
  2. Diabetes mellitus non insulin-dependent
  3. Dyspepsia (indigestion)
  4. Feeling cold
  5. Frequent bowel movements
  6. Gastric ulcer (stomach ulcer)
  7. Hepatic cyst
  8. Inflammation
  9. Intestinal functional disorder
  10. Lethargy (tiredness)

50-59:

  1. Alopecia (absence of hair from areas of the body)
  2. Asthma
  3. B-cell lymphoma (blood cancer affecting b cells)
  4. Breast lump (localized swelling that feels different from the surrounding breast tissue)
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  7. Calcaneal spur (heel spur)
  8. Chest pain
  9. Coeliac disease (simple food intolerance)
  10. Depression

60+:

  1. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  2. Blood creatine phosphokinase increased
  3. Renal impairment (severely reduced kidney function)
  4. Weakness
  5. Aldolase increased
  6. Amputation
  7. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  8. Depressed level of consciousness
  9. Encephalitis viral (inflammation of the brain due to viral infection)
  10. Encephalopathy (functioning of the brain is affected by some agent or condition)

What are the existing conditions these people have? *

  1. Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 2 people, 6.45%
  2. Cytomegalovirus Infection: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Propulsid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cellcept and Propulsid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Propulsid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cellcept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Propulsid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil and cisapride monohydrate (the active ingredients of Cellcept and Propulsid, respectively), and Cellcept and Propulsid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: